HighTower Advisors LLC Invests $355,000 in American Well Co. (NYSE:AMWL)

HighTower Advisors LLC bought a new stake in American Well Co. (NYSE:AMWL) in the third quarter, according to its most recent Form 13F filing with the SEC. The institutional investor bought 37,467 shares of the company’s stock, valued at approximately $355,000. HighTower Advisors LLC owned 0.24% of American Well as of its most recent SEC filing.

A number of other hedge funds have also recently added to or reduced their stakes in AMWL. BNP Paribas Financial Markets acquired a new position in American Well in the third quarter valued at $95,000. PDT Partners LLC acquired a new position in American Well in the 3rd quarter valued at about $107,000. Walleye Capital LLC purchased a new stake in American Well during the 3rd quarter valued at approximately $167,000. Point72 DIFC Ltd lifted its position in American Well by 1,418.5% during the 2nd quarter. Point72 DIFC Ltd now owns 103,457 shares of the company’s stock worth $34,000 after acquiring an additional 96,644 shares during the period. Finally, Cubist Systematic Strategies LLC grew its stake in shares of American Well by 7,673.8% in the 2nd quarter. Cubist Systematic Strategies LLC now owns 184,083 shares of the company’s stock valued at $60,000 after purchasing an additional 181,715 shares during the last quarter. Hedge funds and other institutional investors own 56.05% of the company’s stock.

Analyst Upgrades and Downgrades

Several equities research analysts have recently commented on AMWL shares. Morgan Stanley cut their price target on American Well from $20.00 to $10.50 and set an “equal weight” rating for the company in a research note on Tuesday, December 17th. Needham & Company LLC restated a “hold” rating on shares of American Well in a research report on Thursday, October 31st.

American Well Trading Up 0.4 %

NYSE AMWL opened at $7.87 on Monday. The business’s 50 day moving average is $9.14 and its two-hundred day moving average is $8.67. The stock has a market capitalization of $120.57 million, a price-to-earnings ratio of -0.54 and a beta of 1.07. American Well Co. has a 12-month low of $5.00 and a 12-month high of $31.60.

American Well Company Profile

American Well Corporation, an enterprise platform and software company, delivers digitally enabling hybrid care in the United States and internationally. The company offers Converge, a cloud-based platform that enables health providers, payers, and innovators to provide in-person, virtual and automated care; and delivers virtual primary care, post-discharge follow-up, chronic condition management, virtual nursing, e-sitting, on-demand and scheduled virtual visits, specialty consults, automated care, and behavioral health, as well as specialty care programs, including dermatology, musculoskeletal care, second opinion, and cardiometabolic care to patients and members.